ArticleJournal of oncology2023

Efficacy Evaluation of Bevacizumab Combined with Capecitabine in the Treatment of HER2-Negative Metastatic Breast Cancer: A Meta-Analysis.

Yiyi Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.